Monopar Therapeutics Inc. (MNPR) Stock Rocketing Higher in Premarket. What’s Going on.
Maria Masood
February 18, 2022
Monopar Therapeutics Inc. (MNPR) is a late-stage biotherapeutics company engaged in the development of exclusive therapeutics used to extend the life span of cancer patients.